Home > Products > Veterinary APIs
CasNo: 31430-15-6
MF: C16H12FN3O3
Appearance: almost white powder
Therapeutic Function |
Anthelmintic |
Biochem/physiol Actions |
Flubendazole, an antithelmintic, has been widely used in treating intestinal parasites. Additionally, Flubendazole has been reported to exert anticancer activities. |
Definition |
ChEBI: A member of the class of mebendazole in which the benzoyl group is replaced by a p-fluorobenzoyl group. A broad-spectrum anthelmintic, it is used, particularly in veterinary medicine, for the treatment of nematodal infections. |
General Description |
Flubendazole is a benzimidazole anthelmintic drug that is available from a number of sources. The benzimidazoles are a group of compounds that include albendazole, flubendazole, mebendazole, niridazole, triabendazole, and triclabendazole. |
Uses | Flubendazole, belonging to benzimidazole, is a broad-spectrum insect repellent and has been repurposed as a promising anticancer drug. In recent years, many studies have shown that flubendazole plays an anti-tumor role in different types of cancers, including breast cancer, melanoma, prostate cancer, colorectal cancer, and lung cancer. |
Who Evaluation |
Evaluation year: 1993 |
InChI:InChI=1/C16H12FN3O3/c1-23-16(22)20-15-18-12-7-4-10(8-13(12)19-15)14(21)9-2-5-11(17)6-3-9/h2-8H,1H3,(H2,18,19,20,22)
In our study, we demonstrated that repurposed drug flubendazole (FLU) significantly inhibits proliferation and survival of GBM cells. FLU exerted its effect by affecting microtubule structure and our results also suggest that FLU influences tubulins expression to a certain degree.
FLU suppresses breast cancer through the inhibition of proliferation, metastasis and drug resistance mainly by targeting breast CS-like cells via inhibiting cell cycle progression and tubulin polymerization. FLU suppresses TNBC mainly through the inhibition of breast CS-like cells via inhibiting STAT3 activation; FLU mitigates resistance to trastuzumab through the inhibition of CS-like cell properties and the HER2 pathway, and the induction of apoptosis and G2/M phase arrest in HER2-positive breast cancer
(3,4-diaminophenyl)(4-fluorophenyl)ketone
O-methyl-N-(methoxycarbonyl)-isourea
4-chloro-3-nitrobenzoate
4-chloro-3-nitro-benzoyl chloride
C17H15FN3O7P
C17H15FN3O7P